Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeffrey Mark Rowe Insider Profile
4 Followers
Jeffrey Mark Rowe, Director, Ten Percent Owner at Zomedica Pharmaceuticals, holds 12.24M shares in Zomedica Pharmaceuticals (Ticker: ZOM). Most recently, Jeffrey Mark Rowe ― shares of Zomedica Pharmaceuticals on ― for an estimated value of ―.
Jeffrey Mark Rowe has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jeffrey Mark Rowe's holdings
Insider Roles
Director, Ten Percent Owner
Roles that Jeffrey Mark Rowe holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jeffrey Mark Rowe
Jeffrey Mark Rowe's Trading History
List of latest transactions for each holding click on a transaction to see Jeffrey Mark Rowe's performance on stock
You May Also Like
Jeffrey Mark Rowe insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Mark Rowe?
The percentage of profitable transactions made by Jeffrey Mark Rowe is ―.
What is the average return per transaction made by Jeffrey Mark Rowe?
The average return per transaction made by Jeffrey Mark Rowe is ―.
What stocks does Jeffrey Mark Rowe hold?
Jeffrey Mark Rowe holds: ZOM stocks.
What was Jeffrey Mark Rowe’s latest transaction?
Jeffrey Mark Rowe latest transaction was an Uninformative Buy of ―.
What was Jeffrey Mark Rowe's most profitable transaction?
Jeffrey Mark Rowe’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jeffrey Mark Rowe's role in Zomedica Pharmaceuticals?
Jeffrey Mark Rowe's role in Zomedica Pharmaceuticals is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.